AgelessRx 2026: Longevity Telehealth Platform Overview Treatments, Pricing, Compounded Medications, and What Prospective Patients Should Know
Ann Arbor, MI, March 13, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX),…
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
Lead investor confirmed his intention to maintain his current shareholdings.Company does not…
Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Cosentyx is the only IL-17A inhibitor approved for this population, and the…
Microvast Schedules Fourth Quarter Earnings Call
March 13, 2026 15:00 ET | Source: Microvast Holdings, Inc. STAFFORD, Texas,…
Cloud Signature Consortium Announces Trust Without Borders Summit 2026 in Bogot
Brussels, March 13, 2026 (GLOBE NEWSWIRE) -- The Cloud Signature Consortium (CSC)…
Shekhar Natarajan Introduces Trust Ecology, a New AI Paradigm Built on Angelic Intelligence
SAN FRANCISCO, March 13, 2026 (GLOBE NEWSWIRE) -- In response to the…
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
March 12, 2026 21:03 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026 20:30 ET | Source: Indivior Pharmaceuticals Inc. RICHMOND, Va.,…
VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the…
